Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
4081
Masato Maekawa, Motoko Inomata, Masao S Sasaki, Akihiro Kaneko, Mineko Ushiama, Kokichi Sugano, Jun Takayama, Takashi Kanno
Electrophoretic variant of a lactate dehydrogenase isoenzyme and selective promoter methylation of the LDHA gene in a human retinoblastoma cell lineClin Chem
2002
48(11):1938-45
PubMed ID: 12406979
3455
Inomata M, Saijo N, Kawashima K, Kaneko A, Fujiwara Y, Kunikane H, Tanaka Y
Induction of apoptosis in cultured retinoblastoma cells by the protein phosphatase inhibitor, okadaic acid.J Cancer Res Clin Oncol
1995
121:729-38
PubMed ID: 7499444
DOI: 10.1007/BF01213319
901
M Inomata, A Kaneko, N Saijo, S Tokura
Culture of retinoblastoma cells from clinical specimens: growth-promoting effect of 2-mercaptoethanolJ Cancer Res Clin Oncol
1994
120(3):149-55
PubMed ID: 8263010
DOI: 10.1007/BF01202193
21579
Khade OS, Sasidharan S, Jain A, Maradani BS, Chatterjee A, Gopal D, Ravi Kumar RK, Krishnakumar S, Pandey A, Janakiraman N, Elchuri SV, Gundimeda S.
Identification of dysregulation of sphingolipids in retinoblastoma using liquid chromatography-mass spectrometry.Exp Eye Res
2024
109798
PubMed ID: 38246332
DOI: 10.1016/j.exer.2024.109798
17716
Gopal Divya, Ramani Madhura, Vikas Khetan, Pukhraj Rishi, Janakiraman Narayanan
Understanding the mechano and chemo response of retinoblastoma tumor cellsOpenNano
2022
8:100092
DOI: 10.1016/j.onano.2022.100092
18226
Maradani BS, Parameswaran S, Subramanian K.
Development and characterization of DNA aptamer against Retinoblastoma by Cell-SELEXSci Rep
2022
12(1):16178
PubMed ID: 36171412
DOI: 10.1038/s41598-022-20660-3
21035
Gopal D, Nagarajan H, Muthuvel B, Vetrivel U, George R, Janakiraman N.
Synthesis and Characterization of a Novel Peptide Targeting Human Tenon Fibroblast Cells To Modulate Fibrosis: An Integrated Empirical Approach.ACS Pharmacol Transl Sci
2022
5(12):1254-1266
PubMed ID: 36524010
DOI: 10.1021/acsptsci.2c00148
17040
Sandeep Bose, Amit Chatterjee, Shantha Kumar Jenifer, Biswajit Mondal, Pillalamarri Srikrishnarka, Debasmita Ghosh, Angshuman Ray Chowdhuri, M. P. Kannan, Sailaja V. Elchuri, Thalappil Pradeep
Molecular Materials through Microdroplets: Synthesis of Protein-Protected Luminescent Clusters of Noble MetalsACS Sustainable Chemistry & Engineering
2021
9:4554-4563
DOI: 10.1021/acssuschemeng.0c09145
13082
Raguraman R, Parameswaran S, Kanwar JR, Vasudevan M, Chitipothu S, Kanwar RK, Krishnakumar S.
Gene expression profiling of tumor stroma interactions in retinoblastoma.Exp Eye Res
2020
PubMed ID: 32585195
DOI: 10.1016/j.exer.2020.108067
13774
Ravishankar H, Mangani AS, Shankar MB, Joshi M, Devasena T, Parameswaran S, Subramaniam K.
Characterization of NCC-RbC-51, an RB cell line isolated from a metastatic siteHistochem Cell Biol
2020
153(2):101-109
PubMed ID: 31781967
DOI: 10.1007/s00418-019-01832-1
13939
Ravishankar H, Mangani AS, Phoebe Moses GL, Mani SP, Parameswaran S, Khetan V, Ganesan S, Krishnakumar S.
Serum exosomal miRNA as biomarkers for RetinoblastomaExp Eye Res
2020
108184
PubMed ID: 32795526
DOI: 10.1016/j.exer.2020.108184
12528
Amit C, Muralikumar S, Janaki S, Lakshmipathy M, Therese KL, Umashankar V, Padmanabhan P, Narayanan J.
Designing and enhancing the antifungal activity of corneal specific cell penetrating peptide using gelatin hydrogel delivery systemInt J Nanomedicine
2019
14:605-622.
PubMed ID: 30697045
DOI: 10.2147/IJN.S184911